Related Experiment Video
Updated: Jul 6, 2026
07:32
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Polymer-drug conjugates: recent development in clinical oncology
1Department of Experimental Diagnostic Imaging, Unit 59, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. cli@di.mdacc.tmc.edu <cli@di.mdacc.tmc.edu>
Advanced Drug Delivery Reviews
|April 1, 2008
Summary
Polymer-drug conjugates enhance cancer treatment by delivering drugs directly to diseased sites. Clinical trials show these targeted therapies offer improved efficacy and fewer side effects compared to traditional chemotherapy.
Area of Science:
- Polymer chemistry
- Drug delivery systems
- Oncology
Background:
- Targeted drug delivery aims to improve therapeutic index by concentrating drugs at disease sites and reducing systemic exposure.
- Polymer-drug conjugates utilize synthetic water-soluble polymers as carriers for therapeutic agents.
Purpose of the Study:
- To provide an overview of polymer-drug conjugates that have progressed into clinical trials.
- To discuss preclinical and clinical data for poly(l-glutamic acid)-paclitaxel (PG-TXL).
- To summarize various polymeric conjugates with chemotherapeutic agents.
Main Methods:
- Review of clinical trial data for polymer-drug conjugates.
- Discussion of preclinical pharmacology of PG-TXL.
- Summary of different polymer-drug conjugate systems.
Main Results:
- Poly(l-glutamic acid)-paclitaxel (PG-TXL) has advanced into clinical trials.
- Early clinical trials indicate polymer-drug conjugates offer advantages over parent drugs.
- Demonstrated benefits include reduced side effects, enhanced efficacy, and improved administration/compliance.
Conclusions:
- Polymer-drug conjugates show significant promise in oncology.
- These targeted systems represent a new class of anticancer agents.
- Further clinical development is warranted based on positive trial outcomes.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...